Anixa Biosciences, Inc.
ANIX
$2.77
$0.000.00%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.61M | 1.73M | 1.38M | 1.68M | 1.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.72M | 2.88M | 2.44M | 3.00M | 3.39M |
| Operating Income | -2.72M | -2.88M | -2.44M | -3.00M | -3.39M |
| Income Before Tax | -2.59M | -2.72M | -2.28M | -2.81M | -3.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.59M | -2.72M | -2.28M | -2.81M | -3.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 20.00K | 27.00K | 22.00K | 23.00K | 29.00K |
| Net Income | -2.57M | -2.70M | -2.26M | -2.79M | -3.18M |
| EBIT | -2.72M | -2.88M | -2.44M | -3.00M | -3.39M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.08 | -0.08 | -0.07 | -0.09 | -0.10 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.04 | -0.05 | -0.06 |
| EPS Diluted | -0.08 | -0.08 | -0.07 | -0.09 | -0.10 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.04 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 33.24M | 32.94M | 32.48M | 32.20M | 32.20M |
| Average Diluted Shares Outstanding | 33.24M | 32.94M | 32.48M | 32.20M | 32.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |